Khalid Abou Farha

Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients

H. W. Reesink, Gregory Fanning, Khalid Abou Farha et al. · Gastroenterology · 2009 · 155 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects

A. Marie O'Farrell, André van Vliet, Khalid Abou Farha et al. · Clinical Therapeutics · 2007 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?

Khalid Abou Farha, Richard Bruggeman, Corine Baljé‐Volkers · ISRN Psychiatry · 2014 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY

Hendrik W. Reesink, René Verloes, Khalid Abou Farha et al. · Journal of Hepatology · 2008 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

The Value of Desmethylclozapine and Serum CRP in Clozapine Toxicity: A Case Report

Khalid Abou Farha, André van Vliet, Henderikus Knegtering et al. · Case Reports in Psychiatry · 2012 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16